TLPH Projected Dividend Yield
Talphera Inc ( NASDAQ : TLPH )AcelRx Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Co.'s portfolio consists of nafamostat product candidates and pre-filled syringe product candidates. Co.'s nafamostat product candidates include Niyad™, which is being developed as a regional anticoagulant for injection into the extracorporeal circuit; and LTX-608, which is Co.'s proprietary nafamostat formulation for direct IV infusion. Co.'s pre-filled syringe product candidates include Fedsyra™, which is an ephedrine pre-filled syringe; and the phenylephrine pre-filled syringe. 20 YEAR PERFORMANCE RESULTS |
TLPH Dividend History Detail TLPH Dividend News TLPH Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |